Investors
ESW vision
is completing
its 10 years’
journey
Thanks to our financial investors, Ciclad and MCapital, two French equity funds, entering through an MBO in 2018, the global “kick-off” of our journey has been supported.
A new investment opportunity in Dry Eye innovation
Our Solutions for Advanced Dry Eye Screening and long-lasting efficient Dry Eye Treatment are registered (medical class II / III) in more than 60 countries worldwide. To set up next steps for our future product and market developments, a new opportunity for investors has been opened in June 2026.
Interested in our investment opportunities for our future journey?
Interested in our investment opportunities? Get in touch with our CEO, Petra Bruckmueller (pb@e-swin.com) or directly with our project advisors Rochefort Associates (op@rochefortassocies.com).
Get in touch with our team to learn more
